COMPANY

Calyxo

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $40.1M (Form D filed Apr 16, 2026). SEC Form D 0001668653-26-000001 (Apr 16, 2026)
Evidence (1 event)
- Apr 16, 2026 · SEC Form D 0001668653-26-000001
  Name of Issuer: Calyxo, Inc.; CIK: 1668653; Address: Pleasanton, CA; Submission type: D; Filing date: 2026-04-16; Industry Group: Other Health Care; Date of First Sale: 2026-04-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 40099963; Total Amount Sold: 40099963; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 15, 2026 FDA FDA 510(k) clearance: CVAC® Aspiration System — K261447, Sep 15, 2026. Applicant at approval: Calyxo, Inc. source ↗
Apr 13, 2026 FDA FDA 510(k) clearance: CVAC Aspiration System — K260965, Apr 13, 2026. Applicant at approval: Calyxo, Inc. source ↗
Mar 6, 2026 FDA FDA 510(k) clearance: CVAC Image Processor — K260013, Mar 6, 2026. Applicant at approval: Calyxo, Inc. source ↗

Sep 15, 2026 FDA 510(k) clearance: CVAC® Aspiration System — K261447, Sep 15, 2026. Applicant at approval: Calyxo, Inc. source ↗
Apr 13, 2026 FDA 510(k) clearance: CVAC Aspiration System — K260965, Apr 13, 2026. Applicant at approval: Calyxo, Inc. source ↗
Mar 6, 2026 FDA 510(k) clearance: CVAC Image Processor — K260013, Mar 6, 2026. Applicant at approval: Calyxo, Inc. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12